Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer.
J Clin Invest. 2020 Apr 1;130(4):1653-1668. doi: 10.1172/JCI131041.
J Clin Invest. 2020.
PMID: 32091413
Free PMC article.
Clinical Trial.